IDH1 and neoplasm: The present study demonstrated that tumor hypoxia as assessed by FMISO PET in IDH-wildtype tumors was significantly higher than that in IDH-mutant tumors and that the FMISO uptake value was able to predict the IDH mutation status in newly diagnosed malignant gliomas.